Moors & Cabot’s Prothena Corp PRTA Stock Holding History

Moors & Cabot’s Portfolio PRTA Stock Details PRTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-14,350	Closed	-$143K	–	773
2020 Q3	$143K	Buy	+14,350	New	+$173K	0.01%	631
2020 Q1	–	Sell	-12,050	Closed	-$190K	–	672
2019 Q4	$190K	Buy	+12,050	New	+$129K	0.02%	580
2016 Q2	–	Sell	-5,510	Closed	-$224K	–	542
2016 Q1	$224K	Buy	5,510 +78	+1%	+$3.05K	0.04%	419
2015 Q4	$372K	Sell	5,432 -1,111	-17%	-$67K	0.07%	302
2015 Q3	$298K	Buy	+6,543	New	+$381K	0.06%	364

Other funds holding PRTA

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

Moors & Cabot's PRTA Position: Q4 2020 in Review

Moors & Cabot sold out of Prothena Corp (PRTA) in Q4 2020, closing a stake of 14,350 shares — an estimated $143K sold.

Moors & Cabot first reported a position in PRTA in Q3 2015 and held it in 5 quarters. The position peaked at $372K in Q4 2015. 140 funds tracked by Wall St. Rank hold PRTA as of Q4 2020.

Moors & Cabot reported no remaining Prothena Corp position as of Q4 2020 after selling out during the quarter.
Moors & Cabot sold 14,350 Prothena Corp shares in Q4 2020, an estimated $143K.
Moors & Cabot first reported a position in Prothena Corp in Q3 2015 and held it in 5 quarters.
Moors & Cabot's Prothena Corp position peaked at $372K in Q4 2015.
140 funds tracked by Wall St. Rank held Prothena Corp as of Q4 2020.

Based on Moors & Cabot's 13F filing for Q4 2020, filed 11 Feb 2021.